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2SUMMARY
In spite of their complete lack of any structural features that characterize 
membrane proteins, cytosolic nucleoside-diphosphate kinases (NDPKs) have been found 
repeatedly to associate with membranes. In some instances the recruitment of cytosolic 
NDPKs to membranes was attributed to interactions with peripheral or integral 
membrane proteins, but in many cases the mechanism underlying the association of 
NDPKs with membranes remained unknown. We show here that cytosolic NDPKs bind 
directly to membrane lipids in a dynamic process that is controlled by its substrates, 
nucleoside tri- and diphosphates, and can be fully reconstituted with chemically defined, 
protein-free phospholipids and recombinant NDPK, or with purified NDPK. Our results 
uncover a novel mechanism for the reversible targeting of soluble NDPKs to membranes, 
where they may act as a reservoir of high energy phosphate, supporting the operation of 
membrane-based processes that utilize nucleotides other than ATP, such as intracellular 
traffic and phospholipid biosynthesis.
31. INTRODUCTION
Nucleoside-diphosphate kinases (NDPKs) play a central role in a broad range of 
cellular functions, including nucleic acid synthesis, lipid, and carbohydrate metabolism, 
through their ability to phosphorylate nucleoside diphosphates utilizing the terminal 
phosphate of ATP [1,2]. These enzymes show broad base specificity, but display a 
preference for adenine and guanine nucleotides. The phosphate transfer requires Mg2+
and follows ping-pong kinetics [3], taking place via a phosphohistidine intermediate. The 
reaction occurs in two steps,
E+ N1TPE∙N1TPE~P+N1DP                                           (a)
E~P+N2DPE~P∙N2DPE+N2TP                                       (b)
that combined give the overall reaction sequence:
N1TP+N2DP  N1DP+N2TP                                               (1)
The most ubiquitous members of this family of proteins, NDPK A and B (the 
products of the nm23-1 and -2 genes), are hexamers of two highly (88%) homologous 
polypeptides of ~20 kDa [4], with similar kinetic parameters [5]. NDPK A and B are 
abundant proteins: their estimated cytosolic concentration ranges from 1 to 10 M. While
human NDPK A and B differ markedly in isoelectric point (theoretical pI values are 5.8 
and 8.5 for A and B, respectively), their murine equivalents have pIs around 7. The three-
dimensional structures for human NDPK A and B are very similar [6,7], and the 
monomers of the two proteins can associate, forming hetero-hexamers [4].
NDPK A and B have all the characteristics of cytosolic proteins, with no exposed 
hydrophobic segments or membrane-binding motifs. Yet, purification and 
characterization of NDPK from rat liver plasma membranes reveal that it is identical to 
4the soluble protein [8]. Indeed, in many instances cytosolic NDPKs associate with 
membranes of a wide variety of intracellular compartments. At the plasma membrane 
NDPKs influence the function of ion channels [9], receptor activation and desensitization 
by agonists [10], activation of phagocyte NADPH oxidase [11], dynamin-mediated 
endocytosis [12-14] and integrin-mediated adhesion [15]. Soluble NDPKs also localize to 
endosomes [14], membranes from the endoplasmic reticulum [16-19], the Golgi and 
vesicles budding from the trans-Golgi [16], as well as phagosomes [20]. In some cases 
the recruitment of cytosolic NDPKs to membranes was ascribed to interactions with 
peripheral or integral membrane proteins such as G proteins [21-23], integrin cytoplasmic 
domain associated protein 1- [15], the SET complex [17] and the potassium channel 
KCa3.1 [9]. Overexpression of cytosolic NDPKs revealed novel associations with the 
GTP-bound form of ARF6 [13], the thromboxane A2  receptor [10] and the von-Hippel 
Lindau protein [14], and these binding partners were proposed to anchor NDPK to 
membranes. Recently, NDPKs A and B were found to associate directly with purified 
phospholipids [19, 24].
Intracellular transport of membranes is largely mediated by the microtubular 
network, and treatment of cellular extracts with taxol, followed by pelleting of the 
resulting microtubules and associated structures, allows the rapid isolation and 
characterization of a fraction enriched in trafficking vesicles. This fraction (MT/Ves) has 
been well characterized, and contains microtubules to which are tethered endosomes, 
exocytic and transcytotic vesicles, as well as putative intra-Golgi transport vesicles [25-
28]. We have previously shown that NDPK is present in MT/Ves and that NDPK binds to 
the membranes in this fraction, but not to the microtubules [28]. Furthermore, the binding 
5of NDPK to intracellular membranes is disrupted by high concentrations of nucleotides, 
with an order of selectivity typical of NDPKs. The present work seeks to further 
characterize the association of NDPK with the intracellular vesicles isolated by 
microtubule stabilization. The results indicate that NDPK is present in most of the 
membrane vesicles obtained in this manner. Additionally, it is eluted from these 
membranes by nucleotides not as a complex, but as a single protein, and this is a 
reversible process: as nucleotide concentrations are reduced to micromolar levels, NDPK 
re-binds to membranes. Thus, the levels of nucleotides in the cell have a profound effect 
on the reversible interaction of soluble NDPKs with membranes. Furthermore, the 
nucleotide sensitivity of this process is a consequence of the intrinsic properties of NDPK 
and can be replicated in a simple system consisting of purified soluble NDPKs and 
chemically defined phospholipids.  Taken together, our observations reveal a simple and 
novel mechanism for the reversible targeting of soluble NDPKs to the membranes of 
intracellular transport vesicles, and support the hypothesis that NDPK may play a role in 
localized regeneration of nucleotides such as CTP and GTP, that are essential for the 
biosynthesis of phospholipids as well as intracellular traffic.
62. MATERIALS AND METHODS
2.1. Materials
Nucleotides were from Roche (GTP, GTPS, GMP-PNP) and Sigma-Aldrich
(ATP, ADP, GDPS). Taxol was purchased from Tocris, Sigma-Aldrich or LC 
Laboratories. SDS-PAGE gels (NuPage, 10 or 12%, run in MOPS/SDS buffer) were from 
Invitrogen. PIP strips were from Echelon Biosciences. Anti-nm23 H1/2/3, anti-Arf6, 
and anti-von Hippel-Lindau protein were from Santa Cruz Biotechnology, anti-NDPK 
(Ab-1) and anti--tubulin (Ab-2) from LabVision, anti-dynamin from Calbiochem,    
antibodies to Rac1 were  from Santa Cruz and  Upstate Biotechnology (clone 23A8). 
Polyclonal antibodies to NDPK C (Anti-C), affinity-purified antibodies to NDPK A 
depleted of antibodies cross-reacting with NDPK B (Anti-A), and affinity-purified 
polyclonal antibodies to NDPK B were a generous gift of Dr. Ioan Lascu (Université de 
Bordeaux, France). For specific detection of NDPK B, IgGs cross-reacting with NDPK A 
were removed by chromatography on columns of immobilized NDPK A [29]; the fraction 
obtained is designated here as Anti-B.  Other antibodies were from sources previously 
described [28]. Secondary antibodies labeled with infrared dyes (IRDye 800 anti-rabbit 
and anti-goat, IRDye700 anti-mouse) were from Rockland Immunochemicals. 
Phospholipids (dioleolylphosphatidylcholine (DOPC), dioleoylphosphatidylethanolamine 
(DOPE), dioleoylphosphatidylserine (DOPS), 1,2-dioleoyl-sn-glycerol-3-phosphate 
(DOPA), and carboxyfluorescein-labeled dioleoylphosphatidylethanolamine) were from 
Avanti Polar Lipids.
72.2 Methods
Cell Culture
NIH-3T3 fibroblasts were cultured in Dulbecco’s modiﬁed Eagle’s medium 
supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 1 mM sodium pyruvate, 
100 U/l penicillin and 100 µg/ml streptomycin at 37 °C in a humidiﬁed 5% CO2 
atmosphere. For ATP depletion experiments, cultures were transferred to low glucose 
medium, and were either left untreated in controls, or exposed to 50 mM 2-deoxyglucose 
and 10 mM sodium azide for 1h.
Isolation of microtubule-associated vesicles and cytosol
Microtubule-associated vesicles (MT/Ves) were isolated as described previously 
[28]. Briefly, NIH-3T3 cells were homogenized in MEPS (35 mM PIPES pH 7.1 with 
NaOH, 5 mM MgSO4, 5 mM EGTA, 200 mM sucrose, 1 mM DTT; the calculated free 
Mg2+ is 4.3 mM) containing protease inhibitors (2 mM PMSF, 1 mM benzamidine, 2
g/ml leupeptin). A post-nuclear supernatant (S1) was centrifuged at 40,000 xg for 20 
min. The supernatant (S2; small vesicles and cytosol) was incubated at 37 °C for 30 min 
with 20 µM taxol (and nucleotides when indicated) to polymerize tubulin, and pelleted at 
16,000 xg for 30 min at 4 °C. The pellets were brought to the original volume with 
MEPS, taxol was added to 20 M and the samples were centrifuged at 16,000 xg. After a 
second wash, the pellets were solubilized in SDS-PAGE sample buffer and analyzed by 
SDS-PAGE and immunoblotting. In some instances the pellets were incubated with 
nucleotides after two washes, and then processed for analysis. Samples were 
immunoblotted in parallel with antibodies to -tubulin (and Rab4 or LAMP1, when 
appropriate) to make sure that treatments did not affect tubulin polymerization or co-
pelleting of membrane vesicles. Proteins were detected by chemiluminescence and 
8quantitated with Maxim DL 2.12 (Diffraction Limited) software, or with the LI-COR®
Odyssey infrared imaging system. Results shown are representative of 3-10 separate 
experiments. Cytosol from NIH-3T3 cells was prepared by centrifugation of the S2 
supernatant in a TLA 100.3 rotor at 335,000 xg for 1 h at 4 °C.
Immunofluorescence and Confocal Microscopy
A 10 l aliquot of MT/Ves pellet suspended in MEPS was spread onto polylysine-
coated coverslips and allowed to adhere for 3 min. The specimen was fixed with 4% 
paraformaldehyde for 10 min, washed three times with PBS, incubated with NaBH4 to 
quench free aldehyde groups and processed for indirect immunofluorescence as in [28], 
using an antibody to NDPK (Ab-1; 1:50), followed by Texas Red anti-rabbit (1:100). 
Confocal and differential interference contrast (DIC) images were acquired with an 
Olympus FluoView 300 confocal laser scanning microscope (Olympus, Center Valley, 
PA).
Purification of NDPK from human erythrocytes
Soluble NDPK was purified from human erythrocytes using a modification of an 
earlier protocol [30]. Briefly, red blood cells were lysed in buffer A (25 mM MOPS, 1 
mM EDTA, 1 mM PMSF, pH 7.5) on ice, and centrifuged at 17,600 xg for 1h. The 
supernatant was removed and fractionated with 45%-85% ammonium sulfate. The 85% 
precipitate was suspended in buffer B (20 mM Tris, 1 mM EDTA, pH 8.0), dialyzed to
the same buffer, concentrated on an Amicon XM50 membrane, centrifuged for 15 min at 
48,000 xg, and applied to a Reactive Yellow 3 column. Wash and elution with ATP were 
as described [30], and yielded a mix of NDPKs A and B estimated to be 88% pure by 
SDS-PAGE, with a specific activity of 1,200 U/mg when tested by the coupled assay 
9with 1 mM ATP and 0.2 mM TDP as substrates [30]. The purified preparation (eNDPK) 
was stored at -20 °C in PBS/50% glycerol.
Bacterial expression and purification of human NDPK A
Wild-type NDPK A was expressed in E. coli from a pET 21b vector generously 
provided by Dr. Marie-Lise Lacombe (INSERM U 402, Paris, France), as described [31]. 
Purification was by sequential chromatography in Q-Sepharose and Blue Sepharose as 
described by Lascu et al. [32]. After concentration and desalting the preparation was 
stored in liquid nitrogen. The purified protein (rNDPK A) was electrophoretically 
homogeneous and had a specific activity of 1600 U/mg. 
Size Exclusion Chromatography 
MT/Ves pellets were isolated, and incubated as described above in MEPS buffer 
with 20 µM taxol, with or without 1 mM GTP. After centrifugation at 16,000 xg the 
supernatant was removed and applied to a Superose 12 HR 10/30 (Amersham 
Biosciences) column developed with MEPS buffer at a flow rate of 0.4 ml/min and 
fractions of 1.0 ml were collected. The protein elution profile was monitored at 280 nm, 
and aliquots were assayed for NDPK activity. The samples were precipitated with 
trichloroacetic acid, dissolved in sample buffer and analyzed by SDS-PAGE followed by 
silver staining and/or immunoblotting. The column was calibrated with standards (IgG, 
BSA, -lactoglobulin, cytochrome C and vitamin B12) according to the manufacturer's 
instructions. In earlier experiments we utilized a Sepharose 6 HR 10/30 column with 
similar results. 
Lipid overlay assay
Nitrocellulose membranes pre-spotted with phospholipids (PIP strips) were 
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blocked for 1 h at 25°C with 3% fatty-acid free bovine serum albumin in Tris-buffered 
saline with 0.1% Tween-20 (TBST). Blots were overlaid with 4 ml of 3.75 g/ml purified 
rNDPK A in blocking solution, with or without 1 mM GTP, for 1h at 4 °C. The 
membranes were washed 6 times for 5 min with TBST, and then incubated with primary 
antibody against NDPK for 1 h. After 4 washes, the blot was incubated with secondary 
antibody, washed 4 more times, and developed using enhanced chemiluminescence. The 
same procedure was followed with cytosol from NIH-3T3 cells. 
Liposome Binding Assays
The lipid combinations used were (in molar ratios): DOPC:DOPS, DOPC:DOPE 
and DOPC:DOPA (80:20), and DOPC:DOPE:DOPS, DOPC:DOPE:DOPA (60:20:20). 
Small unilamellar vesicles were prepared by mixing the appropriate combination of lipid 
stock solutions in chloroform in a glass tube. The solvent was evaporated under a stream 
of nitrogen and the samples were further dried in a SpeedVac for 1 h. Lipids (1.8 mol) 
were resuspended in a vortex mixer with 90 l of MEPS buffer with 400 mM sucrose, 
incubated for 1h at room temperature and sonicated on ice in a bath sonicator (Model 
G112SPIT, Laboratory Supply Company, Hicksville, NY) for 8-12 min. Prior to 
experiments, cytosol or purified proteins were diluted in MEPS with 100 mM sucrose and 
centrifuged in a Beckman Airfuge at 167,000 xg for 10 min to remove any aggregates. 
Cytosol (1.5-1.8 mg/ml) or purified NDPK (0.8-5 M) were incubated with liposomes 
(0.4 mg/ml) at 30 °C for 30 min. After centrifugation at 200,000 xg for 30 min at 25 °C 
in a TLA 120.1 rotor, the supernatants were removed and the pellets were resuspended in 
MEPS buffer with or without 1 mM GTP. The samples were incubated for 30 min at 30 
°C and pelleted as above. The supernatants and pellets were resolved by SDS-PAGE and 
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immunoblotted. Lipid recovery was uniform, as established using carboxyfluorescein-
labeled phosphatidylethanolamine (0.2 mol %) as a marker. All results shown are 
representative of 3-6 separate experiments.
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3. RESULTS
We have previously shown that nucleoside diphosphate kinase (NDPK) co-purifies 
with intracellular vesicles associated with taxol-stabilized microtubules (MT/Ves), but 
dissociates from this fraction upon incubation with 1 mM GTP or ATP [28]. Guanine 
nucleotide analogs also elute NDPK from membranes: at 1 mM, GTPS and GDPS are 
as effective as GTP, whereas GMP-PNP induces only a partial release. This order of 
efficacy is not the one expected from the binding site of GTP-binding proteins, where 
GTPS and GMP-PNP act alike, and have opposite effects to those of GDPS. Rather, it 
parallels the rank order of affinity of these compounds for NDPK, leading to the 
suggestion that the nucleotide binding site involved in the dissociation process is that of 
NDPK [28]. The simplest interpretation of this behavior is that binding of nucleotides to 
the active site triggers the dissociation of NDPK from its binding site in the vesicles. On 
the other hand, nucleotides often disrupt interactions between microtubules, motors and 
their membrane cargo [33-35]. We found that dynein and kinesin, as well as Rab4 and 
Lamp1, remained in the pellet after treatment with 1 mM GTP or ATP [28], suggesting 
that the association of motors plus early and late endosomal membranes with  
microtubules was intact. However, the elution of NDPK by nucleotides could be linked to 
the release of yet another component of the fraction. 
3.1. NDPK is the main protein released from membranes by GTP
To determine whether 1 mM GTP dissociated other components concomitantly 
with NDPK, we washed MT/Ves pellets in MEPS buffer with or without 1 mM GTP, 
centrifuged the samples and examined the protein composition of the supernatants by 
SDS-PAGE followed by silver staining and immunoblotting. A prominent band 
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migrating at the position expected for NDPK (~18 kDa) is present in the GTP extract, but 
not in the control (Fig. 1A, arrow). Aside from this band, the protein profiles of control 
and GTP extracts are essentially the same. Immunoblotting with antibodies to NDPKs A, 
B and C indicated that this band consists mostly of NDPK B (Fig. 1B), which is 
expressed at higher levels in murine tissues than other isoforms [16], as well as trace 
amounts of NDPK A. NDPK C is detectable only in the cell lysate. 
3.2. NDPK is released as an active hexamer, without associated proteins
To confirm the identity of this protein as NDPK, the supernatants obtained in the 
presence of GTP were further analyzed by size-exclusion chromatography, and the 
NDPK content of individual fractions was measured using enzyme activity assays, SDS-
PAGE and immunoblotting. As seen in Figure 1C, the GTP extract contains NDPK 
activity that elutes in one peak centered at approximately 100 kDa, the size expected for a 
hexamer of 18 kDa subunits. The enzyme activity overlaps with a band identifiable as 
NDPK by immunoblotting (Fig. 1D). A similar analysis of control extracts shows no 
NDPK activity above basal levels and no reactivity with antibodies to NDPK in 
immunoblots (not shown). These experiments verify that the 18 kDa band seen in Figure 
1A is NDPK, and show that GTP releases enzymatically active NDPK, in its native, 
hexameric state. Moreover, the apparent molecular mass of 100 kDa demonstrates that 
NDPK is released alone, and not in a complex with other proteins. 
We also performed immunoblot analyses of the MT/Ves pellet with antibodies 
against known NDPK binding partners, such as Arf6, dynamin, Rac1, and the von 
Hippel-Lindau protein. Only Rac1 and Arf6 were detected in the MT/Ves pellet, and 
neither was released upon nucleotide treatment (not shown).  In addition, although [-
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32P]-GTP overlay assays of the MT/Ves fraction revealed the presence of several small 
GTP binding proteins, none were released by GTP treatment (not shown).
3.3. The binding of NDPK to intracellular vesicles is controlled by its catalytic cycle
GTP, ATP and the thiophosphate analogues GTPS and GDPS, which bind 
tightly to NDPKs [5] release similar amounts of NDPK from the MT/Ves fraction, 
whereas GMP-PNP, which binds with low affinity to NDPK, is far less effective [28]. 
This suggests that the nucleotide effects on the association of NDPK to membranes are 
intimately linked to its catalytic properties. To address this issue in depth, we determined 
the dose-response relationships for release of NDPK from the MT/Ves fraction by GTP, 
ATP, ADP, GTPS and GDPS. 
As the concentration of GTP or ATP increases from 1 M to 1 mM, the amounts 
of NDPK bound to the MT/Ves pellet in the presence of GTP or ATP decreases markedly 
(Fig. 2A). GTPS and GDPS inhibit binding in a dose-dependent manner and with 
significantly higher potency than ATP or GTP. In contrast, ADP decreases the amount of 
NDPK bound by 70-80% at all concentrations tested. 
While the results obtained at high concentrations of nucleotides confirm our 
previous data on the dissociation of NDPK from membranes, examination of the effects 
of low concentrations of these compounds offers a new insight into the association 
process. Unexpectedly, the lowest concentration of GTP and ATP, 1 M, consistently 
raised the amount of NDPK associated with MT/Ves to 120-125% of the control value. 
This increase is not observed with the GTP analog GTPS which binds to NDPK with 
relatively high affinity, but is a poor substrate for phosphate transfer [5], and suggests 
that only nucleotides that transfer phosphate to NDPK can promote the association of 
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NDPK with membranes. If so, reducing the concentration of E~P should promote 
dissociation. Indeed, ADP, which is an acceptor for the phosphate of E~P and thus 
dephosphorylates the enzyme, induces dissociation even at 1 M. In contrast, at 1 M, 
GDPS, which is a poor phosphate acceptor, has little or no effect on the association of 
NDPK with membranes. Collectively, these data indicate that the association of NDPK 
with intracellular vesicles is a reversible process whose dynamics are controlled by the 
relative amounts of the phosphorylated intermediate, E~P, and the free enzyme, E.
If this reasoning is correct, a reduction in the [NTP]/[NDP] ratio in cells, which 
necessarily decreases the [E~P]/[E] ratio, should decrease significantly the amounts of 
NDPK bound to MT/Ves. To test this hypothesis, we assessed the levels of NDPK in 
MT/Ves fractions isolated from cells pre-incubated with the glycolysis inhibitor 2-
deoxyglucose and the mitochondrial poison sodium azide (D/A), a treatment that 
markedly depletes cytosolic ATP (and consequently other NTPs), and reduces markedly 
the [ATP]/[ADP] ratio, as well as the levels of free ATP and GTP [36]. Figure 2B shows 
that MT/Ves pellets prepared from cells pre-treated with D/A contain only traces of 
NDPK (7±5 % of control, n=4), as would be expected if the association of NDPK to 
MT/Ves depended on the levels of ATP. There is, however, the possibility that the 
decrease in binding is due to a secondary effect of the D/A treatment, which could 
decrease the number of NDPK binding sites on the MT/Ves fraction or induce a decline 
in the actual amounts of cytosolic NDPK. To address this point, we performed several 
control experiments: in one, we incubated MT/Ves pellets obtained from D/A-treated 
cells with cytosol from the control cells, centrifuged the preparation and measured NDPK 
in the pellet. This same procedure was repeated using cytosol from D/A-treated cells, and 
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from control cells, which were incubated with MT/Ves pellets that had been stripped of 
NDPK with 1 mM GTP and therefore contain significant amounts of residual GTP. The 
results in Figure 2B show that in all cases NDPK re-bound to the MT/Ves fraction. This 
set of experiments indicates that both MT/Ves membranes and cytosolic NDPK from 
D/A-treated cells retain their ability to associate, as long as the NTP concentration in the 
incubation mixture is at a minimum level. Therefore, the lower binding of NDPK to 
MT/Ves isolated from cells treated with D/A is likely to be the consequence of a lowered 
[ATP]/[ADP] ratio.
3.4. NDPK localizes to the majority of vesicular structures associated with MT
Our previous biochemical data indicate that in the MT/Ves fraction NDPK is not 
associated directly with microtubules [28], given that when the polymerization of tubulin 
with taxol was performed after membranes have been removed by centrifugation at 
230,000 xg, NDPK was absent from the microtubular pellet [28]. This lack of direct 
interaction between NDPK and microtubules is in agreement with observations by others 
[37, 38]. Analysis of the taxol-stabilized MT/Ves fraction by confocal 
immunofluorescence and DIC confirms this idea. MT/Ves pellets isolated from NIH-3T3 
cells were placed on polylysine-coated coverslips, and processed for indirect 
immunofluorescence using an antibody to NDPK. As shown in Figure 3, NDPK localizes 
to numerous structures of varied size and shape, most of them organized in linear arrays 
along the microtubules that are clearly visible in the corresponding DIC image. Similar 
DIC images have been obtained with microtubules polymerized with taxol from purified 
tubulin [39, 40]. The heterogeneity of the vesicles and their irregular distribution along 
the microtubules is typical of similar fractions obtained from hepatocytes [25, 26] and 
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3T3-L1 adipocytes [27] by the same protocol utilized here. Thus, transmission electron 
microscopy of this fraction has revealed microtubules with many vesicles of variable size 
and appearance attached along their lengths [25, 26].  Inspection of Figure 3 also 
demonstrates that NDPK localizes to nearly all of the vesicular structures visible in the 
DIC image. The widespread distribution of NDPK seen in experiments like the one in 
Figure 3 suggests that it binds to a universal component of intracellular membranes, 
namely lipids. This would agree with recent results showing that NDPKs A and B bind to 
acidic phospholipids [19, 24]. Thus, our next step was to determine whether nucleotides 
affect the direct association of NDPK with lipids.
3.5. NDPK binds to phospholipids in a nucleotide sensitive manner
In preliminary tests we used a protein lipid overlay assay. Membrane strips pre-
spotted with different phospholipids were incubated with cytosol from NIH-3T3 cells, as 
well as purified NDPKs, and then probed with antibodies against NDPK. Figure 4 
illustrates the results obtained with rNDPK A, in the presence and absence of GTP. The 
enzyme displays a preference for PtdIns(5)P, PtdIns(3)P, PtdIns(4)P, PtdIns and PS. 
When GTP is added, the binding of rNDPK A to all these phospholipids is decreased, but 
the extent of the GTP-induced reduction varies from 66% (PS) to 35% (PtdIns(3)P) of the 
control value. The enzyme from cytosol also binds to PS and phosphoinositides, albeit 
with a slightly distinct selectivity (not shown). There was no detectable binding of murine 
or human NDPK to immobilized PC, PE, sphingosine phosphate or lysophospholipids. 
Although this type of assay does not necessarily reflect binding affinity or specificity in 
solution, and sometimes fails to detect all the phospholipids to which a protein actually 
binds [41], it is clear from Figure 4 that purified recombinant NDPK A can bind to pure 
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phospholipids, as reported by Tokarska-Schlattner et al. [24], and does so in a GTP-
sensitive manner.
We then examined how the nucleotide-sensitive binding of NDPK to pure lipids 
translated into a more physiological experimental system, that is, liposomes, using a 
sedimentation method [42]. Briefly, NDPK from cytosol was incubated with sucrose-
loaded small unilamellar vesicles of defined phospholipid composition. The samples 
were pelleted by ultracentrifugation and the level of NDPK bound to the liposomes was 
measured as in Methods. Figure 5 shows that cytosolic NDPK from NIH-3T3 bound to 
liposomes of different compositions, showing a preference for PA-containing mixes. 
There was negligible binding to liposomes made of pure PC (not shown). This result is in 
agreement with the finding that purified NDPK A and B prefer anionic to neutral 
phospholipids [19, 24]. More importantly, in the presence of 1mM GTP (or ATP), the 
levels of cytosolic NDPK associated with liposomes were noticeably reduced. Similar 
results were obtained with purified eNDPK (Fig. 5, lower panel) and rNDPK A (not 
shown): the purified proteins bound to several combinations of phospholipids, and the 
binding was decreased by 1 mM GTP or ATP. Note that the last step of the purification 
procedures for both rNDPK A and eNDPK involves elution of the enzyme from a dye 
column with ATP; as a result, both preparations are likely to be partially phosphorylated 
[43] and therefore able to associate with liposomes in the absence of added NTP.
Taken together, these findings imply that the mechanism of binding to the 
liposomes and to the MT/Ves isolated from cells is essentially the same. Furthermore, the 
results shown in Figures 4 and 5 (lower panel) demonstrate conclusively that the 
nucleotide-sensitive binding of NDPK to intracellular membranes can be reconstituted 
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with a minimal set of components, namely purified enzyme and lipids.
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4. DISCUSSION
Our results confirm recent work [19, 24] showing that soluble NDPKs can 
associate with membranes by binding directly to lipids. The interaction does not require 
additional proteins, although it is conceivable that it might be strengthened by additional 
interactions with other membrane components. Also, the data suggest that the form with 
highest affinity for lipids is the phosphoenzyme. Therefore, the equilibrium between 
membrane-bound and soluble NDPK will be determined by the availability of the 
phosphorylated enzyme. 
The equilibrium constant of reaction (a), 
[E~P][NDP]  [E][NTP]
lies in the range of 0.15 to 0.5 for NDPKs of various species (reviewed in [44]). The 
concentration of ATP in vivo exceeds those of other NTPs, so [NTP]/[NDP] is 
approximately equal to the [ATP]/[ADP] ratio, which in most cells, including NIH-3T3 
fibroblasts [45], is around 10. Under these conditions, the ratio [E~P]/[E] is 1.5-5, 
allowing the binding of NDPK to membranes. 
Because of the ping-pong mechanism of NDPK (Figure 6), NDPs not only 
dephosphorylate E~P, but also bind to the free enzyme, E, acting as dead end inhibitors 
[3]. In either case, if E~P is the form that associates with membranes, NDPs, in this case 
ADP, should inhibit binding at all concentrations, either by removing free enzyme 
available for phosphorylation, or by dephosphorylating E~P, and this is what is seen in 
Figure 2. 
NDPK’s Km for ATP is 0.3 mM, one order of magnitude lower than the Ki for dead 
end inhibition, 3 mM [3]. Thus, the binding of NTPs to E~P forming abortive complexes 
(E~P∙NTP) (Figure 6) is only observed at very high concentrations of NTP, and in the 
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absence of significant amounts of NDPs. This explains the progressive reduction in the 
amounts of NDPK associated with membranes as the concentration of ATP (and GTP) is 
raised. The marked difference in the behavior of phosphorylating (ATP, GTP) and non-
phosphorylating (GTPS) nucleotides is a result of the balance between phosphorylation 
and inhibition, which is significant for the natural nucleotides, but is heavily biased 
towards inhibition in the case of the thio-modified nucleotide. 
Two critical questions remain: where does the lipid bind, and how is the catalytic 
cycle of NDPK coupled to the association and dissociation from membranes? The 3D 
structures of hexameric NDPK show a symmetrical arrangement that can be described as 
two identical trimers superimposed horizontally, forming a disk with a diameter of 70Ǻ 
and a thickness of 50Ǻ (reviewed in [46]). There is a single nucleotide-binding site per 
subunit, and the top and bottom surfaces of the disk contain three active sites each. The 
binding site lies in a crevice lined with basic residues, between a loop and a hairpin 
formed by helices A and 2. Preliminary studies using in silico docking indicate that 
this site might accomodate a phospholipid such as PA. In this aspect NDPK is 
reminiscent of the phosphatidylethanolamine-binding protein (PEBP), a 23 kDa basic 
protein that binds phospholipids as well as GTP [47]. Similarly to NDPK, in the crystal 
structure of PEBP the ligand binding site lies in a narrow crevice near the surface, 
proximal to a strip of basic residues. Like NDPK, the bovine PEBP structure is not 
related to other nucleotide binding proteins, or to known lipid-binding proteins. Notably, 
the loop connecting helices A and 2 contains the conserved basic residues K56 and 
R58, newly identified as essential for the binding of NDPK B to acidic phospholipids 
[19]. A previous, groundbreaking report by Epand et al. [48] demonstrated novel 
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properties of the mitochondrial NDPK isoform, NDPK D (or NM23-H4), namely the 
ability to cross-link bilayers and transfer lipids between them, provided that cardiolipin is 
present. These observations were recently expanded by Tokarska-Schlattner et al. [24], 
who demonstrated that NDPK-D binds strongly to other acidic phospholipids as well, and 
that residue R90 (D57 in NDPKs A and B) from the same loop is essential for the binding 
of NDPK-D to artificial and native membranes.  Additionally, results from Orlov et al. 
[21] are consistent with an involvement of the A-2 hairpin in the association process. 
Briefly, a synthetic peptide with a sequence that encompasses helix A dissociates 
NDPK B from rod outer segment membranes, whereas peptides homologous to other 
portions of the protein have no effect.  
There are no detectable differences between the 3D structures of the 
phosphorylated NDPK and the free enzyme [49], but binding of nucleotides to the active 
site results in a small conformational change, where the A-2 hairpin moves 2Ǻ and 
locks the nucleotide in place. This suggests a mechanism by which the conformational 
change associated with nucleotide binding could trigger dissociation of NDPK from 
bilayers: in E~P, the nucleotide binding site is in the "open" conformation, allowing its 
binding to phospholipids, while occupation of the site, followed or not by phosphate 
transfer to NDP, closes the cleft and releases the enzyme from the lipid. Soluble NDPK is 
eventually rephosphorylated by NTP, and is again capable of associating with membrane 
lipids.
In conclusion, our present studies suggest that in vivo the high [ATP]/[ADP] ratio 
promotes phosphorylation of NDPK and its association with membranes, where it could 
transfer phosphate to locally generated NDPs. Schneider et al. [50] suggested that 
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because of its high concentration in the cytosol and the expected prevalence of its 
phosphorylated state at normal [ATP]/[ADP] ratios, soluble NDPKs could serve as a 
cellular reservoir of high energy phosphate. Targeting of such a reservoir to membranes 
may be relevant to the operation of the pathways of phospholipid synthesis, which require 
CTP (reviewed in [51]), as well as the multiple GTPases that control intracellular 
membrane transport.
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FIGURE LEGENDS
Figure 1- NDPK-B is the major protein dissociated from membranes by GTP, and 
behaves as a hexamer, without associated proteins. 
A. MT/Ves pellets were washed twice with MEPS (containing protease inhibitors 
and 20 M taxol), and then incubated in the same buffer in the absence (Ctr) or presence 
of 1 mM GTP. After centrifugation for 30 min at 4°C the supernatants were processed for 
SDS-PAGE, resolved in a 12% NuPage gel and stained with silver. B. Immunoblot 
analysis of the control (C) and GTP extracts obtained as above, as well as whole cell 
lysates (L) from NIH-3T3 cells, with  antibodies specific to NDPK-A (Anti-A), NDPK-B 
(Anti-B) and polyclonal antibodies to NDPK-C (Anti-C). C. GTP extracts were obtained 
as above and fractionated on Superose 12 as described in Methods. Fractions were 
assayed for NDPK activity. The elution positions of standards are indicated by (in kDa): 
a, 158; b, 67; c, 35, and d, 12.4. D. Immunoblot of column fractions from C with 
antibodies to NDPK B (Anti-B). Results shown are representative of 5 independent 
experiments.
Figure 2- The interaction of NDPK with membranes is controlled by its substrates, and is 
abolished by ATP depletion.
A. Nucleotides were present during taxol-induced polymerization of microtubules 
at the concentrations indicated. The amounts of NDPK in the resulting MT/Ves pellets 
were assessed as in Methods. Values shown are ratios of the amounts of NDPK in 
nucleotide-treated samples to those measured in controls run in parallel with no added 
nucleotides, expressed as percent of control. n = 2-3 for GTPS and GDPS, and 3-9 for 
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ATP, GTP and ADP. Error bars indicate S.E. of means. B. Cells were kept in low glucose 
medium (4 samples) or treated with deoxyglucose and azide (D/A; 2 samples) as in 
Methods. Following polymerization with taxol and centrifugation, supernatants (Ctr SN, 
D/A SN) were removed and pellets were washed twice. Three Ctr samples were extracted 
with 1 mM GTP and pelleted (GTP pellet). Pellets were then resuspended as follows: one 
each of Ctr, D/A, and GTP pellets in MEPS buffer (-), one each of D/A and GTP pellets
in Ctr SN, and one GTP pellet in D/A SN. After 30 min on ice, samples were centrifuged 
and the pellets were analyzed by SDS-PAGE followed by immunoblotting with 
antibodies to NDPK B (Anti-B). Results are representative of 3 experiments.
Figure 3- NDPK localizes to most vesicular structures associated with microtubules. 
Samples were prepared as in Methods; the antibody to NDPK was Ab-1. Left 
panel: Confocal immunofluorescence of MT/Ves pellets showing localization of NDPK 
(red) to many vesicular structures of varying sizes and shapes that are often distributed 
along linear tracks. Right panel: the corresponding DIC image demonstrates that most of 
these vesicles are associated with the underlying microtubular network. Comparison of 
the two panels reveals that nearly all the vesicles seen in the DIC image contain NDPK.
Figure 4- rNDPK A binds to immobilized phospholipids in a GTP-sensitive manner. 
PIP strips were incubated with purified rNDPK A as described in Methods, in 
the presence and absence of 1 mM GTP, and the bound protein was detected with 
antibodies to NDPK A (Anti-A). The location of each lipid is shown in the diagram on 
the right. Abbreviations are: S1P, sphingosine-1-phosphate; LPA, lysophosphatidic acid; 
PtdIns(3,4)P2, phosphatidylinositol (3,4) bisphosphate; LPC, lysophosphocholine; 
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PtdIns(3,5)P2, phosphatidylinositol (3,5) bisphosphate; PtdIns, phosphatidylinositol; 
PtdIns(4,5)P2, phosphatidylinositol (4,5) bisphosphate; PtdIns(3)P, phosphatidylinositol 
(3) phosphate; PtdIns(3,4,5)P3, phosphatidylinositol (3,4,5) trisphosphate; PtdIns(4)P, 
phosphatidylinositol (4) phosphate; PA, phosphatidic acid; PtdIns(5)P, 
phosphatidylinositol (5) phosphate; PS, phosphatidylserine; PE, 
phosphatidylethanolamine; PC, phosphatidylcholine.
Figure 5- Interaction of NDPK from cytosol and purified eNDPK with liposomes of 
defined composition.
Liposomes were incubated with cytosol from NIH-3T3 cells (upper panel) or with 
purified eNDPK (lower panel) as described in Methods, centrifuged, and washed with 
buffer alone or buffer containing 1 mM GTP. The bound protein was detected by SDS-
PAGE and immunoblotting with Anti-nm23 H1/2/3. Abbreviations are: PC: 
dioleylphosphatidylcholine, PE: dioleylphosphatidylethanolamine, PS: 
dioleylphosphatidylserine and PA: 1,2-dioleoyl-sn-glycero-3-phosphate. The bar graph 
shows the average band intensity measured in 4 experiments, normalized to protein.  
Error bars are S. E. of means. 
Figure 6- Scheme of NDPK-catalyzed phosphate transfer in the presence of 
phospholipids (Cleland notation).
E: free enzyme; EN1TP: enzyme-substrate (nucleoside triphosphate1) complex; 
E~PN1DP: phosphorylated enzyme-product (nucleoside diphosphate1) complex; E~P: 
phosphorylated enzyme intermediate; E~PN2DP: phosphorylated enzyme-substrate 
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(nucleoside diphosphate2) complex; EN2TP: enzyme-substrate (nucleoside triphosphate2) 
complex; ENDP, E~PNTP: dead-end complexes formed at high concentrations of NDP 
or NTP; E~PLipid: proposed phosphorylated enzyme-phospholipid complex.
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